• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
LYU Yaping,ZHAO Na,SUN Yuanpeng,XIE Yan,ZHANG Junlin.General considerations for the prescription and process developmentof chemical generic compound bilayer tablets[J].Journal Of Pharmaceutical Research,2026,45(2):182-187[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3018times   Download 979次 QR Code for this article
Scan with your phone!
化学仿制药复方双层片处方工艺开发一般考虑
率亚平,赵娜,孙元朋,谢琰,章俊麟
Font:Larger+|Default|Smaller-
(国家药品监督管理局药品审评中心,北京 100076)
摘要:
复方双层片剂可通过联合用药或调整释药速率的方式来增强药效、减轻药物的不良反应、提高患者依从性,是固体制剂领域广受关注的新型制剂。本文结合文献专利、国内外药品相关法律法规和指导原则,对化学仿制药复方双层片在处方筛选和工艺开发过程中的关注点进行总结,包括原料药的粉体学性质、辅料筛选、多规格处方设计、双层压片工艺的开发和批量放大等,以期对化学仿制药复方双层片的开发提供一定的参考。
关键词:  复方双层片  粒径分布  处方工艺开发
DOI:10.13506/j.cnki.jpr.2026.02.010
基金项目:
Publication Date:February 25, 2026
General considerations for the prescription and process developmentof chemical generic compound bilayer tablets
LYU Yaping,ZHAO Na,SUN Yuanpeng,XIE Yan,ZHANG Junlin
(Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, China)
Abstract:
Compound bilayer tablets have been widely concerned in the development of novel solid formulations because of its advantages including enhancing drug efficacy, reducing side effects and improving patient compliance by combining medications or adjusting the rate of drug release. This review summarizes the key points in prescription screening and process development of chemical generic compound bilayer tablets, combining the literature patents, relevant domestic and foreign drug laws and regulations. This includes the characteristics of active pharmaceutical ingredients, the selection of excipients, the design of multi-strengths prescription, the development of bi-layer process and batch amplification, etc., in order to provide a reference for generic compound bilayer tablets drug development.
Key words:  Compound bilayer tablets  Particle size distribution  Prescription and process development
Today's Visits:465    Total Visits:2383161
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.